Finance

Beta
Lists
008930:KRX
Hanmi Science Co Ltd
₩29,700.00
+4.39%
(+1,250.00) 1D
Jun 9, 3:30:28 PM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 008930...
Open
₩28,600
High
₩30,500
Low
₩28,500
Mkt. cap
2.03T
Avg. vol.
127.39K
Volume
80.31K
Dividend
1.01%
Quarterly dividend
₩75
Ex-dividend date
Mar 30, 2026
P/E ratio
14.79
52-wk high
₩55,500
52-wk low
₩28,100
EPS
₩2,008
Shares outstanding
68.39M
No. of employees
476
Open
₩28,600
High
₩30,500
Low
₩28,500
Mkt. cap
2.03T
Avg. vol.
127.39K
Volume
80.31K
Dividend
1.01%
Quarterly dividend
₩75
Ex-dividend date
Mar 30, 2026
P/E ratio
14.79
52-wk high
₩55,500
52-wk low
₩28,100
EPS
₩2,008
Shares outstanding
68.39M
No. of employees
476
News stories
From sources across the web
About Hanmi Science Co Ltd
CEOSong Young-sook
Employees476
Founded1973
HeadquartersSeoul, Songpa District, South Korea
SectorHealth care provider
Previous reportsAll values in KRW
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in KRW
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
377.04B
362.10B
285.67B
375.62B
Cost of goods sold
260.67B
-
260.59B
273.66B
Cost of revenue
260.67B
-
260.59B
273.66B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
59.58B
322.80B
66.60B
66.10B
Operating expense
61.86B
322.80B
69.10B
68.40B
Total operating expenses
322.53B
322.80B
329.69B
342.06B
Operating income
54.51B
39.30B
-44.02B
33.56B
Other non operating income
269.66K
-14.01M
2.88B
-22.70M
EBT including unusual items
31.55B
37.62B
37.17B
45.33B
EBT excluding unusual items
31.64B
37.57B
38.89B
45.33B
Income tax expense
3.22B
5.74B
4.11B
3.05B
Effective tax rate
10.22%
15.27%
11.05%
6.72%
Other operating expenses
-
-
-
-
Net income
28.76B
32.28B
32.26B
42.71B
Net profit margin
7.63%
8.92%
11.29%
11.37%
Earnings per share
-
-
-
-
Interest and investment income
487.64M
486.63M
510.38M
524.08M
Interest expense
-2.64B
-2.56B
-2.59B
-2.81B
Net interest expenses
-2.15B
-2.07B
-2.08B
-2.28B
Depreciation and amortization charges
2.28B
-
2.50B
2.30B
EBITDA
56.83B
41.59B
-41.51B
35.86B
Gain or loss from assets sale
363.00K
-547.73K
-1.75M
-13.26B
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more